ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 014,03
0,96%
Dow Jones
38 711,29
0,00%
DAX
18 601,15
1,00%
Brent Oil
77,81
0,91%
Bitcoin
70 833,83
0,30%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. 10x Genomics Inc (TXG)

  7. 10x Genomics Inc (TXG) Actualités

TXG

10x Genomics (TXG)

10x Genomics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TXG
DateHeureSourceTitreSymboleSociété
31/05/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
29/05/202422h05PR Newswire (US)10x Genomics Launches 5,000-Plex Gene Panel for XeniumNASDAQ:TXG10x Genomics Inc
22/05/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
02/05/202422h05PR Newswire (US)10x Genomics to Present at the BofA Securities 2024 Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
30/04/202422h05PR Newswire (US)10x Genomics Reports First Quarter 2024 Financial ResultsNASDAQ:TXG10x Genomics Inc
10/04/202422h05PR Newswire (US)10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:TXG10x Genomics Inc
26/03/202414h00PR Newswire (US)10x Genomics Commercially Launches Visium HD Spatial Gene Expression AssayNASDAQ:TXG10x Genomics Inc
21/03/202421h05PR Newswire (US)10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelNASDAQ:TXG10x Genomics Inc
13/03/202421h05PR Newswire (US)10x Genomics Begins Commercial Shipments of Chromium GEM-X ProductsNASDAQ:TXG10x Genomics Inc
20/02/202422h05PR Newswire (US)10x Genomics to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:TXG10x Genomics Inc
15/02/202423h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TXG10x Genomics Inc
15/02/202423h16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TXG10x Genomics Inc
15/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
15/02/202422h05PR Newswire (US)10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024NASDAQ:TXG10x Genomics Inc
07/02/202422h05PR Newswire (US)10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X TechnologyNASDAQ:TXG10x Genomics Inc
05/02/202422h05PR Newswire (US)10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General MeetingNASDAQ:TXG10x Genomics Inc
24/01/202422h05PR Newswire (US)10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024NASDAQ:TXG10x Genomics Inc
08/01/202415h00PR Newswire (US)10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 ResultsNASDAQ:TXG10x Genomics Inc
21/12/202322h05PR Newswire (US)10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
20/12/202322h05PR Newswire (US)10x Genomics Launches Xenium Catalyst NetworkNASDAQ:TXG10x Genomics Inc
19/12/202315h00PR Newswire (US)Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor InvasivenessNASDAQ:TXG10x Genomics Inc
13/12/202322h26PR Newswire (US)High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking PreprintNASDAQ:TXG10x Genomics Inc
07/12/202315h00PR Newswire (US)10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human BrainNASDAQ:TXG10x Genomics Inc
17/11/202323h22PR Newswire (US)10x Genomics Wins Another Patent Infringement Case Against NanoString TechnologiesNASDAQ:TXG10x Genomics Inc
06/11/202322h05PR Newswire (US)OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC StudyNASDAQ:TXG10x Genomics Inc
02/11/202321h05PR Newswire (US)10x Genomics Reports Third Quarter 2023 Financial ResultsNASDAQ:TXG10x Genomics Inc
01/11/202321h05PR Newswire (US)10x Genomics to Present at the Stephens 25th Annual ConferenceNASDAQ:TXG10x Genomics Inc
26/10/202322h05PR Newswire (US)Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain TumorsNASDAQ:TXG10x Genomics Inc
11/10/202322h05PR Newswire (US)10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:TXG10x Genomics Inc
10/10/202318h06PR Newswire (US)10x Genomics Comments on Second UPC Preliminary Injunction DecisionNASDAQ:TXG10x Genomics Inc
 Showing the most relevant articles for your search:NASDAQ:TXG

Dernières Valeurs Consultées

TG
BPC
Timber Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés